AI in Healthcare: Medical Imaging and Embedded Device Engineering

What does Physical AI mean in medicine?

Consider a laboratory instrument that observes a sample carrier, a rehabilitation prototype that measures movement, or a robotic assistant that responds to sensor feedback. Each combines physical observations with computation and an output someone can use. The output might guide an operator, organize a task or contribute to a device function.

Begin by writing the intended purpose in plain language. Who will use the system? In which environment? What does it observe? What output does it provide, and who decides what happens next? A system that moves supplies around a hospital should not inherit the claims or assumptions of a device used in patient care.

For AI-enabled medical devices in the United States, the FDA describes an approach that considers intended use and technological characteristics. A device's market pathway cannot be inferred from its processor or from the label “AI.” See the FDA's AI-enabled medical device overview. Requirements in other markets need their own assessment with the responsible manufacturer and regulatory specialists.

Application areas worth evaluating

These examples describe possible engineering projects. They do not claim that Alvexis currently supplies approved medical devices or clinically validated AI algorithms.

A useful project brief distinguishes the sensing subsystem, the AI function and the final product. A successful camera integration does not by itself validate a clinical interpretation. A working model demonstration does not by itself establish electrical, mechanical or workflow suitability.

Design the measurement path and the decision path together

Define the interface between these stages. For a sensing prototype, record units, sampling rates, calibration parameters and any transformations applied before storage. For an image pipeline, include exposure, optics and illumination in the configuration. Changes to acquisition can change the meaning of an algorithm's input.

Specify what an invalid observation looks like. A disconnected sensor, poor contact, obscured view or out-of-range signal should not silently become an ordinary result. Include an explicit unavailable or uncertain state when appropriate, and decide how the user or downstream function responds.

Local processing may reduce the amount of raw data that needs to leave the device and may help a workflow operate during a network interruption. It does not automatically make a product private or secure. Define retained data, authorized access, transmission, deletion and maintenance interfaces for the particular installation.

What changes when the prototype becomes a physical product?

Packaging and installation are part of the development scope. Discuss contact conditions, cleaning methods, mounting, connector access, thermal limits and service procedures with the product owner. The responsible team should identify which electrical, mechanical, usability and regulatory evaluations apply to the intended device.

Build the power and thermal plan around the full workload. Acquisition, processing, display, communications and logging may run together. Measure sustained behaviour inside the proposed enclosure and during the intended duty cycle. An accelerator's peak specification is not a complete product performance result.

Plan access for calibration, manufacturing test and fault investigation. A custom carrier can provide the required interfaces and fit, but also creates responsibilities for component availability, board verification and configuration control. The custom carrier-board guide explains those project dependencies.

Keep engineering verification and clinical evidence distinct

Engineering verification can establish that a subsystem measures, processes and communicates according to its specifications. Clinical evaluation asks whether the final function performs appropriately for its intended medical purpose. Neither should be substituted for the other.

The FDA, Health Canada and MHRA transparency principles emphasize clear intended use, users, populations, workflow, performance and limitations. They also discuss communicating changes and monitoring performance. For a project team, these are useful prompts for specifying what evidence and user information the product needs.

The FDA's GMLP resource points to IMDRF principles covering the medical device lifecycle. Development planning should include the deployed product and its changes, rather than ending when a model is trained.

One way to organize the project is a traceability table: for every claimed function, record the required input conditions, output, verification method, owner and acceptance evidence. Include failure cases and human review. Freeze the hardware, software, model and configuration used for each evaluation so results can be interpreted and reproduced.

A practical first pilot

1. Agree on purpose and ownership. Identify the manufacturer, intended users, clinical partners where relevant and the team responsible for acceptance.
2. Choose a narrow question. Examples include measurement repeatability, sample-position observation or equipment-state detection under defined conditions.
3. Define the reference. Specify the measurement or review process used to assess outputs. Agree on the data permissions before collecting patient-related information.
4. Instrument the prototype. Record timing, input quality, processing status and the device configuration alongside the result.
5. Review the evidence before expansion. Decide what the prototype demonstrates, what remains uncertain and what additional evaluation is needed for the intended product.

Keep a research or engineering demonstration's boundary explicit in the pilot agreement. Expanding from observation to a care decision or physical action changes what must be established before use.

Where Alvexis fits in the development program

Alvexis can discuss custom electronic design, sensor interfaces, embedded software support and mechanical integration with medical OEMs, research teams and system integrators. The first conversation should identify the engineering subsystem and the evidence the wider product program will require.

Any medical-specific suitability, quality-system responsibilities, clinical claims and market authorization must be established for the agreed project. This article describes an engineering approach; it is not a claim that an existing Alvexis platform is medically certified or cleared for diagnosis or treatment.

For the broader context, read Physical AI across industries. For movement, perception and embedded control boundaries, continue with the Robotics AI guide.

Embedded systems and computer vision in medical-device development

A medical-device engineering brief should separate image acquisition, computer vision processing and the action taken from the result. Each part has its own interfaces and verification evidence. Define the intended setting, sensor configuration, data quality checks and handling of unavailable or unreliable results before selecting an embedded platform.

Edge AI can reduce the need to transmit raw sensor data, but local processing alone does not establish privacy, clinical performance or suitability for medical use. Those requirements belong to the complete device and its intended use. This architecture discussion is a development framework, not evidence that a component or algorithm is clinically validated.

Discuss the embedded hardware scope